As of 2024-12-15, the Relative Valuation of Oyster Point Pharma Inc (OYST) is (75.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.17 USD, the upside of Oyster Point Pharma Inc based on Relative Valuation is -773.1%.
The range of the Relative Valuation is (33.56) - (113.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 17.3x | 11.0x |
| Forward P/E multiples | 5.1x - 18.5x | 11.8x |
| Fair Price | (33.56) - (113.84) | (75.18) |
| Upside | -400.4% - -1119.2% | -773.1% |
| Date | P/E |